Anti-GITR [DTA-1]

Absolute Antibody

Anti-GITR [DTA-1]

9

This antibody is specific for murine GITR, a member of the tumor necrosis factor receptor (TNFR) family that is expressed at low levels on unstimulated T cells, B cells, and macrophages. Upon activation, CD4+ and CD8+ T cells up-regulate GITR expression,

This antibody has been used in various FACS analyses for diverse immuno-oncological applications, such as to delineate how membrane-organizing protein moesin controls Treg differentiation and antitumor immunity via TGF-beta signaling (Ansa-Addo et al, 2017), to suggest the therapeutic potential of TGF-beta-induced Tregs (iTregs) in treating autoimmune gastritis (Nguyen et al, 2014), and to demonstrate that costimulation with the ligand of GITR elicites dose-dependent enrichment for cells of lower TCR affinity in the Treg cell repertoire (Mahmud et al, 2014). This antibody has also been used in Western Blots to elucidate the mechanism of human T-cell leukemia virus type 1 (HTLV-1) in the development of neoplastic and inflammatory diseases (Satou et al, 2011), and in immunoprecipitation analysis to aid the investigation of the role of GITR in dominant immunological self-tolerance maintained by CD25+CD4+ regulatory T cells (Shimizu et al, 2002). In addition, the anti-tumour effects of this agonistic anti-GITR antibody have been demonstrated in various murine models (Scirka et al, 2017; Coe et al, 2010; Cohen et al. 2010; Hu et al, 2008; Ko et al, 2005).

Flow Cytometry, ImmunoPrecipitation, Western Blot, Other Application

Research Use Only

Monoclonal

DTA-1

Tnfrsf18

tumor necrosis factor receptor superfamily, member 18

AITR; Gi; Gitr; glucocorticoid-induced TNFR-related protein; tumor necrosis factor receptor superfamily member 18

Rat

IgG2b

Tumor necrosis factor receptor superfamily member 18

Mouse

-20°C,2°C to 8°C

12352203